Literature DB >> 11916490

Clinical protocol. Liposomal gene therapy with the herpes simplex thymidine kinase gene/ganciclovir system for the treatment of glioblastoma multiforme.

Jürgen Voges, Friedrich Weber, Regina Reszka, Volker Sturm, Andreas Jacobs, Wolf-Dieter Heiss, Ottmar Wiestler, Joachim Friedrich Kapp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11916490     DOI： 10.1089/10430340252837260

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  10 in total

Review 1.  Human gene therapy and imaging in neurological diseases.

Authors:  Andreas H Jacobs; Alexandra Winkler; Maria G Castro; Pedro Lowenstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

2.  Widespread gene transfer to malignant gliomas with In vitro-to-In vivo correlation.

Authors:  Karina Negron; Namir Khalasawi; Billy Lu; Chi-Ying Ho; Jason Lee; Siddharth Shenoy; Hai-Quan Mao; Tza-Huei Wang; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2019-04-09       Impact factor: 9.776

3.  Minimizing the non-specific binding of nanoparticles to the brain enables active targeting of Fn14-positive glioblastoma cells.

Authors:  Craig S Schneider; Jimena G Perez; Emily Cheng; Clark Zhang; Panagiotis Mastorakos; Justin Hanes; Jeffrey A Winkles; Graeme F Woodworth; Anthony J Kim
Journal:  Biomaterials       Date:  2014-12-13       Impact factor: 12.479

Review 4.  Overcoming barriers in non-viral gene delivery for neurological applications.

Authors:  Aaron Tasset; Arjun Bellamkonda; Wenliang Wang; Ilya Pyatnitskiy; Deidra Ward; Nicholas Peppas; Huiliang Wang
Journal:  Nanoscale       Date:  2022-03-10       Impact factor: 8.307

Review 5.  Gene Delivery in Neuro-Oncology.

Authors:  Karan Dixit; Priya Kumthekar
Journal:  Curr Oncol Rep       Date:  2017-09-02       Impact factor: 5.075

Review 6.  Clinical gene therapy for brain tumors. Liposomal delivery of anticancer molecule to glioma.

Authors:  Jun Yoshida; Masaaki Mizuno
Journal:  J Neurooncol       Date:  2003-12       Impact factor: 4.130

7.  Antitumor therapy mediated by 5-fluorocytosine and a recombinant fusion protein containing TSG-6 hyaluronan binding domain and yeast cytosine deaminase.

Authors:  Joshua I Park; Limin Cao; Virginia M Platt; Zhaohua Huang; Robert A Stull; Edward E Dy; Jeffrey J Sperinde; Jennifer S Yokoyama; Francis C Szoka
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

Review 8.  Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma.

Authors:  Amy Lee Bredlau; Suraj Dixit; Chao Chen; Ann-Marie Broome
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

9.  Highly PEGylated DNA Nanoparticles Provide Uniform and Widespread Gene Transfer in the Brain.

Authors:  Panagiotis Mastorakos; Clark Zhang; Sneha Berry; Yumin Oh; Seulki Lee; Charles G Eberhart; Graeme F Woodworth; Jung Soo Suk; Justin Hanes
Journal:  Adv Healthc Mater       Date:  2015-03-11       Impact factor: 9.933

Review 10.  Imaging in gene therapy of patients with glioma.

Authors:  A H Jacobs; J Voges; L W Kracht; C Dittmar; A Winkeler; A Thomas; K Wienhard; K Herholz; W D Heiss
Journal:  J Neurooncol       Date:  2003-12       Impact factor: 4.506
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.